The Hot Stock: Under Amour Skyrockets 9.9%

BP-AA313_HOTSTO_D_20170425140113.jpg

Source: Blogs Barrons Stocks To WatchUnder Armour (UAA) soared to the top of the S&P 500 today after reporting better-than-expected earnings today.Under Armour gained 9.9% to $21.67 today, while the S&P 500 ticked up 0.1% to 2,388.77.Cowen’s John Kernan and team credit short covering for the big move in Under Armour today:UAA’s Q1 results saw International, which is 20% … [Read more...]

Under Armour: The Bad News in the Good

ON-CB711_UA2017_D_20170403130250.jpg

Source: Blogs Barrons Stocks To WatchUnder Armour (UAA) has been down so long that heading into its earnings report this morning, it was naturally assumed that there wasn’t much it could do to change its fortunes. How wrong the bears were.Under Armour reported a loss of 1 cent a share, better than the 4 cent loss analysts had been predicting. Sales rose to $1.12 billion, b … [Read more...]

The Biggest Loser: Teradata Tumbles 8.3%

BP-AA314_Crash2_D_20170425141332.jpg

Source: Blogs Barrons Stocks To WatchTeradata (TDC) tumbled to the bottom of the S&P 500 today after reporting better-than-expected earnings but missed on revenue.Teradata dropped 8.3% to $29.36 today, while the S&P 500 ticked up 0.1% to 2,388.77.Hilliard Lyons analyst Stephen Turner calls today’s selloff in Teradata “justified.” He explains why:We believe the pullback i … [Read more...]

Three Biotechs Enter…One Biotech Gains

ON-CC539_BIO201_D_20170427154912.jpg

Source: Blogs Barrons Stocks To WatchThree biotech stocks–Alexion Pharmaceuticals (ALXN), Amgen (AMGN), and Celgene (CELG)–reported earnings since yesterday’s close. But just one has seen its shares head higher after the announcement.That would be Alexion, which reported a profit of $1.38, beating forecasts for $1.23, according to Reuters, on sales of $870 million, ahead of anal … [Read more...]

Bristol-Myers: Not Dead Yet?

Money.Roll_Stock.Chart_500x300

Source: Blogs Barrons Stocks To WatchRemember when Bristol-Myers Squibb tumbled in August after announcing that a late-stage trial for the use of Opdivo in lung cancer failed to meet its primary endpoint? Well, Bristol is starting to make back some of those losses after releasing better-than-expected earnings today.Bristol-Myers reported a profit of 84 cents a share, topping … [Read more...]

O’Reilly Auto: Blame Amazon…or Blame the Weather?

Lightbulb_Money.Sign2_500x300

Source: Blogs Barrons Stocks To WatchO’Reilly Automotive (ORLY has been range for much of the last year and a half, as concerns about the impact of Amazon.com (AMZN) on its business vied with its historical dominance.It looks like the bears have come out on the winning side of the trade after O’Reilly reported earnings last night. O’Reilly reported a profit of $2.83 cents a shar … [Read more...]

Another Gold Miner, Another Earnings Tumble

BP-AA239_gld_D_20170405164224.jpg

Source: Blogs Barrons Stocks To WatchEarnings season has not been good for gold miners. Barrick Gold (ABX) tumbled 11% on Tuesday when it missed earnings forecasts, while Newmont Mining (NEM) fell 2.4% despite reporting a better-than-expected profit. Now it’s Goldcorp’s (GG) turn to tumble after releasing earnings.On the surface, earnings were quite good. Goldcorp reported a pro … [Read more...]

Barrick & Newmont: All That Glitters is Not Gold

ON-CB509_GOLD20_D_20170328134904.jpg

Source: Blogs Barrons Stocks To WatchShares of Barrick Gold (ABX) and Newmont Mining (NEM) and tumbling today as investors react to their earnings reports and gold prices fall.Barrick Gold has tumbled 9.7% to $17.20 at 11:48 a.m. today after missing earnings forecasts and cutting its full-year production guidance, while Newmont has dropped 4% to $32.36 despite beating earnings … [Read more...]

U.S. Steel: You’re Missing the Point!!!

ON-CC501_trump_D_20170426171454.jpg

Source: Blogs Barrons Stocks To WatchYesterday, U.S. Steel (X) lost a quarter of its value after reporting a surprise loss. While some analysts were dismayed by the loss, others are sticking with positive ratings, particularly after digging into the numbers.Case in point: JPMorgan analyst Michael Gambardella and team, who leave their Overweight rating and $46 price target … [Read more...]

Yes, Boeing is Still a Sell, Goldman Sachs Says

ON-CC037_cathay_D_20170412233754.jpg

Source: Blogs Barrons Stocks To WatchBoeing (BA) beat earnings forecasts and raised it’s guidance yesterday morning, but shares dropped 1% as investors deemed the better-than-expected profit a lower quality beat. Still, the damage wasn’t much for a stock that has gained 17% so far this year, and 28% during the past six months.Still, Goldman Sachs analyst Noah Poponak and team ar … [Read more...]